Cholangiocarcinoma (CCA), the second most frequent liver cancer after hepatocellular
carcinoma, has been rising worldwide in recent epidemiological research. This neoplasia's …

Cholangiocarcinoma (CCA) are a heterogeneous group of tumors in terms of aetiology,
natural history, morphological subtypes, molecular alterations and management, but all …

Simple Summary Cholangiocarcinoma (CCA) is a heterogenous and aggressive
malignancy of the intra-and extrahepatic biliary tract, marked by a steeply rising incidence …

The effective management of biliary tract cancers (BTCs) has been hampered by limited
options for systemic therapy. In recent years, the focus on precision medicine has made …

Simple Summary Early and non-invasive diagnosis of cholangiocarcinoma (CCA) is still
challenging, thus largely contributing to the increased mortality rates observed worldwide …

Bile-duct cancers (BDC) are a group of solid tumors arising from the biliary tree. Despite
their classification as rare cancers, the incidence of BDC is increasing worldwide. Poor …

Cholangiocarcinoma (CCA), an aggressive malignancy, is typically diagnosed at an
advanced stage. It is associated with dismal 5-year postoperative survival rates, generating …

Cholangiocarcinoma is an uncommon and highly aggressive biliary tract malignancy with
few manifestations until late disease stages. Diagnosis is currently achieved through a …

Cholangiocarcinoma, also referred to as CCA, is a highly complex epithelial malignancy that
can impact various organs and regions of the body, including the perihilar, intrahepatic, and …

Sampling of bile juice during endoscopic retrograde cholangiopancreatography (ERCP) has
potential benefit of being amenable to the identification of novel biomarkers in liquid biopsy …